Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 168

The DOI matches its Crossref record.

A new statistical procedure for testing equivalence in two-group comparative bioavailability trials

Hauck, Walter W., Anderson, Sharon·1984·Journal of Pharmacokinetics and Biopharmaceutics

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/bf01063612

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 13

  1. S. Anderson and W. W. Hauck. A new procedure for testing equivalence in comparative bioavailability and other clinical trials.Comm. Stat. A12:2663–2692 (1983). · DOI
  2. C. W. Dunnett and M. Gent. Significance testing to establish equivalence between treatments, with special reference to data in the form of 2×2 tables.Biometrics 33: 593–602 (1977). · DOI
  3. T. B. L. Kirkwood. Bioequivalence testing—a need to rethink.Biometrics 37: 589–591 (1981). · DOI
  4. D. Mandallaz and J. Mau. Comparison of different methods for decision-making in bioequivalence assessment.Biometrics 37: 213–222 (1981). · DOI
  5. C. M. Metzler. Bioavailability—a problem in equivalence.Biometrics 30: 309–317 (1974). · DOI
  6. C. M. Metzler and D. C. Huang. Statistical methods for bioavailability and bioequivalence.Clin. Res. Pract. Drug Res. Affairs 1: 109–132 (1983). · DOI
  7. M. R. Selwyn, A. P. Dempster, and N. R. Hall. A Bayesian approach to bioequivalence for the 2×2 changeover design.Biometrics 37: 11–21 (1981). · DOI
  8. W. J. Westlake. Use of confidence intervals in analysis of comparative bioavailability trials.J. Pharm. Sci 61: 1340–1341 (1972). · DOI
  9. W. J. Westlake. The design and analysis of comparative blood-level trials. In J. Swarbrick (ed),Current Concepts in the Pharmaceutical Sciences, Dosage Form Design and Bioavailability, Lea & Febiger, Philadelphia, 1973, pp. 149–179.
  10. W. J. Westlake. Symmetric confidence intervals for bioequivalence trials.Biometrics 32: 741–744 (1976). · DOI
  11. W. J. Westlake. Design and statistical evaluation of bioequivalence studies in man. In J. Blanchard, R. W. Sawchuk, and B. B. Brodie (ed),Principles and Perspectives in Drug Bioavailability, Karger, Basel, 1979, pp. 192–210.
  12. W. J. Westlake. Response to bioequivalence testing—a need to rethink.Biometrics 37: 591–593 (1981).
  13. D. Clayton and A. Leslie. The bioavailability of erythromycin stearate versus enteric-coated erythromycin base when taken immediately before and after food.J. Int. Med. Res. 9: 470–477 (1981). · DOI

Cited by

Metadata

Authors
Hauck, W. W., & Anderson, S.
Venue
Journal of Pharmacokinetics and Biopharmaceutics
Published
1984-02
Volume
12
Issue
1
Pages
83-91
ISSN
0090-466X
Cited by
168
References
0
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.